Literature DB >> 10547142

Is age-related maculopathy associated with Alzheimer's Disease? The Rotterdam Study.

C C Klaver1, A Ott, A Hofman, J J Assink, M M Breteler, P T de Jong.   

Abstract

The authors examined the relation between age-related maculopathy and Alzheimer's disease in the Rotterdam Study, a prospective population-based study in the Netherlands. From 1990 to mid-1993, subjects aged 75 years or older (n = 1,438) were screened for the presence of age-related maculopathy and Alzheimer's disease, and follow-up examinations were conducted from mid-1 993 to the end of 1994. Subjects with advanced age-related maculopathy at baseline showed an increased risk of incident Alzheimer's disease (relative risk = 2.1, 95% confidence interval: 1.1, 4.3; adjusted for age and gender), but this risk decreased after additional adjustment for smoking and atherosclerosis (relative risk = 1.5, 95% confidence interval: 0.6, 3.5). These findings suggest that the neuronal degeneration occurring in age-related maculopathy and Alzheimer's disease may, to some extent, have a common pathogenesis.

Entities:  

Mesh:

Year:  1999        PMID: 10547142     DOI: 10.1093/oxfordjournals.aje.a010105

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  56 in total

Review 1.  Epidemiology of age-related maculopathy: a review.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 2.  Genetic factors of age-related macular degeneration.

Authors:  Jingsheng Tuo; Christine M Bojanowski; Chi-Chao Chan
Journal:  Prog Retin Eye Res       Date:  2004-03       Impact factor: 21.198

Review 3.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

Review 4.  The management of sleep and circadian disturbance in patients with dementia.

Authors:  Qiuping Pearl Zhou; Lorena Jung; Kathy C Richards
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

5.  Comorbid visual and cognitive impairment: relationship with disability status and self-rated health among older Singaporeans.

Authors:  Heather E Whitson; Rahul Malhotra; Angelique Chan; David B Matchar; Truls Østbye
Journal:  Asia Pac J Public Health       Date:  2012-04-24       Impact factor: 1.399

6.  Prevalence and patterns of comorbid cognitive impairment in low vision rehabilitation for macular disease.

Authors:  Heather E Whitson; Deidra Ansah; Diane Whitaker; Guy Potter; Scott W Cousins; Heather MacDonald; Carl F Pieper; Lawrence Landerman; David C Steffens; Harvey J Cohen
Journal:  Arch Gerontol Geriatr       Date:  2009-05-07       Impact factor: 3.250

7.  Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study.

Authors:  Lajos Csincsik; Thomas J MacGillivray; Erin Flynn; Enrico Pellegrini; Giorgos Papanastasiou; Neda Barzegar-Befroei; Adrienne Csutak; Alan C Bird; Craig W Ritchie; Tunde Peto; Imre Lengyel
Journal:  Ophthalmic Res       Date:  2018-04-05       Impact factor: 2.892

8.  Complement factor H Y402H polymorphism is not associated with late-onset Alzheimer's disease.

Authors:  Gillian Hamilton; Petra Proitsi; Julie Williams; Michael O'Donovan; Michael Owen; John Powell; Simon Lovestone
Journal:  Neuromolecular Med       Date:  2007-09-22       Impact factor: 3.843

9.  Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.

Authors:  Mark W Logue; Matthew Schu; Badri N Vardarajan; John Farrell; Kathryn L Lunetta; Gyungah Jun; Clinton T Baldwin; Margaret M Deangelis; Lindsay A Farrer
Journal:  Neurobiol Aging       Date:  2013-12-19       Impact factor: 4.673

10.  A low-vision rehabilitation program for patients with mild cognitive deficits.

Authors:  Heather E Whitson; Diane Whitaker; Guy Potter; Eleanor McConnell; Fay Tripp; Linda L Sanders; Kelly W Muir; Harvey J Cohen; Scott W Cousins
Journal:  JAMA Ophthalmol       Date:  2013-07       Impact factor: 7.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.